EP Patent

EP2081921A1 — Short-acting benzodiazepine salts and their polymorphic forms

Assigned to Paion UK Ltd · Expires 2009-07-29 · 17y expired

What this patent protects

The invention relates to besylate salts of the compound of formula (I):Methods of preparing the salts, and their use as medicaments, in particular for sedative or hypnotic, anxiolytic, muscle relaxant, or anticonvulsant purposes is also described.

USPTO Abstract

The invention relates to besylate salts of the compound of formula (I):Methods of preparing the salts, and their use as medicaments, in particular for sedative or hypnotic, anxiolytic, muscle relaxant, or anticonvulsant purposes is also described.

Drugs covered by this patent

Patent Metadata

Patent number
EP2081921A1
Jurisdiction
EP
Classification
Expires
2009-07-29
Drug substance claim
No
Drug product claim
No
Assignee
Paion UK Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.